title: Diabetic macular edema: New promising therapies.
abstract: The treatment of diabetic macular edema is rapidly evolving. The era of laser therapy is being quickly replaced by an era of pharmacotherapy. Several pharmacotherapies have been recently developed for the treatment of retinal vascular diseases such as diabetic macular edema. Several intravitreal injections or sustained delivery devices have undergone phase 3 testing while others are currently being evaluated. The results of clinical trials have shown the superiority of some of these agents to laser therapy. However, with the availability of several of these newer agents, it may be difficult to individualize treatment options especially those patients respond differently to various therapies. As such, more effort is still needed in order to determine the best treatment regimen for a given patient. In this article, we briefly summarize the major new therapeutic additions for the treatment of diabetic macular edema and allude to some future promising therapies.
authors.affiliation: Hanan N Al Shamsi, Jluwi S Masaud, Nicola G Ghazi, The Vitroretinal Division, King Khaled Eye Specialist Hospital, Riyadh 11462, Saudi Arabia.
authors.forename: Hanan N Al
authors.initials: HN
authors.lastname: Shamsi
authors.affiliation: Hanan N Al Shamsi, Jluwi S Masaud, Nicola G Ghazi, The Vitroretinal Division, King Khaled Eye Specialist Hospital, Riyadh 11462, Saudi Arabia.
authors.forename: Jluwi S
authors.initials: JS
authors.lastname: Masaud
authors.affiliation: Hanan N Al Shamsi, Jluwi S Masaud, Nicola G Ghazi, The Vitroretinal Division, King Khaled Eye Specialist Hospital, Riyadh 11462, Saudi Arabia.
authors.forename: Nicola G
authors.initials: NG
authors.lastname: Ghazi
keywords: Diabetic macular edema; Diabetic retinopathy; Intravitreal injection; Laser photocoagulation; Pharmacotherapy; Sustained release drug delivery devices; Vitrectomy